Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...

GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States ...

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs.The Basel-based company, whose array of ...

the Swiss pharma giant said. Once capacity comes online at the various facilities, Roche will export more medicines from the United States than it imports, the Basel company said. The United ...

Swiss pharmaceuticals giant Roche announced Tuesday that it plans to invest $50 billion in the US in pharmaceuticals and diagnostics amid fears about the effects of possible new US tariffs on ...

Roche, a Swiss pharmaceutical giant, will invest $50 billion in the United States over the next five years, creating 12,000 jobs and expanding manufacturing, distribution, and research.

Roche says its imports into US offset by its ... Trump earlier this month reiterated plans for a "major" tariff on pharmaceutical imports, threatening an interwoven global supply chain and ...

These investments further strengthen Roche’s already significant US footprint with 13 manufacturing and 15 R&D sites across the Pharmaceutical and Diagnostics Divisions, and are expected to ...

Negotiations between the US and India – another major pharma supplier – are currently ongoing. Roche's decision to invest heavily in the US – along with Novartis' announcement, has come hard ...